Phillip L. Pearl

Results of phase II pharmacokinetic study of levetiracetam for prevention of post-traumatic epilepsy.

Childhood sleep disorders: diagnostic and therapeutic approaches.

Can stimulant rebound mimic pediatric bipolar disorder?

The neurobiology of autism: new pieces of the puzzle.

Too much energy for rest. Sleep problems in children with ADHD.

Landau-Kleffner syndrome.

Magnetic resonance spectroscopy of neurotransmitters in human brain.

Succinic semialdehyde dehydrogenase deficiency in children and adults.

Murine succinate semialdehyde dehydrogenase deficiency.

Significant behavioral disturbances in succinic semialdehyde dehydrogenase (SSADH) deficiency (gamma-hydroxybutyric aciduria).

Sawtooth wave density analysis during REM sleep in normal volunteers.

Sleep problems, stimulants, and ADHD: true, true, unrelated?

A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.

Pediatric neurotransmitter diseases.

Clinical aspects of the disorders of GABA metabolism in children.

Monitoring gamma-hydroxybutyric acid levels in succinate-semialdehyde dehydrogenase deficiency.

22q13 deletion syndrome with central diabetes insipidus: a previously unreported association.

The Landau-Kleffner Syndrome.

Imaging data in autism: from structure to malfunction.

Seizures and metabolic disease.

Pediatric sleep disorders.

Methylphenidate HCl: therapy for attention deficit hyperactivity disorder.

Use of complementary and alternative therapies in epilepsy: cause for concern.

Inherited disorders of neurotransmitters in children and adults.

Expression profiling reveals multiple myelin alterations in murine succinate semialdehyde dehydrogenase deficiency.

Addendum to assessment: prevention of post-lumbar puncture headaches: report of the TTAS of the AAN.

Clinical experience with anticonvulsant medication in pediatric epilepsy and comorbid bipolar spectrum disorder.

Diagnosis and treatment of neurotransmitter disorders.

The benefits of a camp designed for children with epilepsy: evaluating adaptive behaviors over 3 years.

The pediatric neurotransmitter disorders.

Misidentification of vagus nerve stimulator for intravenous access and other major adverse events.

Ketogenic diet: stoking energy stores and still posing questions.

Parenting stress and childhood epilepsy: the impact of depression, learning, and seizure-related factors.

Infantile seizures: infants are not just little children.

Neuropsychiatric morbidity in adolescent and adult succinic semialdehyde dehydrogenase deficiency patients.

A 2-year-old male with developmental delay, irritability, and failure to thrive.

Cerebral MRI abnormalities associated with vigabatrin therapy.

Teaching Video NeuroImages: preserved awareness in a frontal seizure with bilateral motor involvement: a psychogenic mimic.

Neurological problems of jazz legends.

Polysomnographic abnormalities in succinic semialdehyde dehydrogenase (SSADH) deficiency.

Neuropathology in succinic semialdehyde dehydrogenase deficiency.

Cerebellar atrophy in human and murine succinic semialdehyde dehydrogenase deficiency.

Uveitis and white matter abnormalities in pediatric sarcoidosis.

Succinic semialdehyde dehydrogenase: biochemical-molecular-clinical disease mechanisms, redox regulation, and functional significance.

Center for Neuroscience and Behavioral Medicine: an innovative administrative structure and possible paradigm for the future.

Novel SCN1A mutation in a proband with malignant migrating partial seizures of infancy.

Assessment of genetics knowledge and skills in medical students: insight for a clinical neurogenetics curriculum.

Epilepsy in succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism.

Herbs in epilepsy: evidence for efficacy, toxicity, and interactions.

The effect of seizure focus on regional language processing areas.

GABAB-ergic motor cortex dysfunction in SSADH deficiency.

Thirty years beyond discovery--clinical trials in succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism.

Results of phase 2 safety and feasibility study of treatment with levetiracetam for prevention of posttraumatic epilepsy.

Comment: Right-sizing adult neurology training for the child neurologist.

Therapeutic efficacy of magnesium valproate in succinic semialdehyde dehydrogenase deficiency.

Partial Pyridoxine Responsiveness in PNPO Deficiency.

Monoamine neurotransmitter deficiencies.

Psychiatric symptoms in children prior to epilepsy surgery differ according to suspected seizure focus.

Quantitation of gamma-hydroxybutyric acid in dried blood spots: feasibility assessment for newborn screening of succinic semialdehyde dehydrogenase (SSADH) deficiency.

Metabolic causes of epileptic encephalopathy.

Inherited disorders of GABA metabolism.

Response to Stove and colleagues concerning newborn screening of succinic semialdehyde dehydrogenase (SSADH) deficiency in dried blood spots.

Results of phase II levetiracetam trial following acute head injury in children at risk for posttraumatic epilepsy.

Practice patterns of mitochondrial disease physicians in North America. Part 1: diagnostic and clinical challenges.

Subthalamic nucleus involvement in children: A neuroimaging pattern-recognition approach.

Taurine trial in succinic semialdehyde dehydrogenase deficiency and elevated CNS GABA.

Pyridoxine or pyridoxal-5'-phosphate for neonatal epilepsy: the distinction just got murkier.

International telemedicine consultations for neurodevelopmental disabilities.

Survey of the professors of child neurology: neurology versus pediatrics home for child neurology.

Widening Phenotypic Spectrum of AADC Deficiency, a Disorder of Dopamine and Serotonin Synthesis.

Phenotypic analysis of epilepsy in the mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes-associated mitochondrial DNA A3243G mutation.

Genetic forms of epilepsies and other paroxysmal disorders.

Disorders of GABA metabolism: SSADH and GABA-transaminase deficiencies.

Inherited disorders of gamma-aminobutyric acid metabolism and advances in ALDH5A1 mutation identification.

Neuroimaging features of Cornelia de Lange syndrome.

Erratum to: Widening Phenotypic Spectrum of AADC Deficiency, a Disorder of Dopamine and Serotonin Synthesis.

The genetics of the epilepsies.

Neural Mechanisms Underlying Musical Pitch Perception and Clinical Applications Including Developmental Dyslexia.

Clinical Use of CSF Neurotransmitters.

Gene sleuthing in pyridoxine-dependent epilepsy.

Natural history of succinic semialdehyde dehydrogenase deficiency through adulthood.

Utility of initial EEG in first complex febrile seizure.

From gene discovery to precision intervention in epilepsy: almost the end of the beginning.

Epileptogenesis in neurocutaneous disorders with focus in Sturge Weber syndrome.

Acute Infantile Encephalopathy as Presentation of Succinic Semialdehyde Dehydrogenase Deficiency.

SCN8A encephalopathy: Research progress and prospects.

Biomarkers in a Taurine Trial for Succinic Semialdehyde Dehydrogenase Deficiency.

Real-time multi-channel monitoring of burst-suppression using neural network technology during pediatric status epilepticus treatment.

American Clinical Neurophysiology Society Guideline 5: Minimum Technical Standards for Pediatric Electroencephalography.

Amenable Treatable Severe Pediatric Epilepsies.

SCN2A-Related Early-Onset Epileptic Encephalopathy Responsive to Phenobarbital.

SLC6A1 Mutation and Ketogenic Diet in Epilepsy With Myoclonic-Atonic Seizures.

KCNQ2 encephalopathy: Features, mutational hot spots, and ezogabine treatment of 11 patients.

Texting rhythm with temporal predominance.

Incidence and Geographic Distribution of Succinic Semialdehyde Dehydrogenase (SSADH) Deficiency.